Veracyte, Inc. Veracyte, Inc.

Veracyte, Inc.

VCYT

Classement en actions #4353
Veracyte, Inc. operates as a diagnostics company in the United States and... Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Prix de l'action
$44.93
Dernière synchronisation: 2026-10-20
Capitalisation boursière
$3.61B
Changement (1 jour)
2.57%
Changement (1 an)
24.45%
Pays
US
Échange Veracyte, Inc. (VCYT)

Catégorie

Healthcare
Historique des divisions d’actions pour Veracyte, Inc. (VCYT)
L’action Veracyte, Inc. (symbole : VCYT) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Oct 21, 2026.
Une action VCYT achetée avant le Oct 21, 2026 équivaudrait aujourd’hui à 0 actions VCYT.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
Pas assez de données pour les dates fournies.
Divisions d’actions d’entreprises similaires ou concurrentes
Entreprise Nombre de divisions d’actions Multiplicateur cumulatif Pays
8 x34
US
7 x47
US
0 -
US
0 -
CN
1 x1
US